Clinical Trials Browser

OTHER × Interventional × lestaurtinib × Clear all

NCT00084422 2023-04-10

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00668421 2014-11-26

CEP-701 (Lestaurtinib) in Myelofibrosis

Phase 1/2 Unknown

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis